Elsevier

Regulatory Peptides

Volume 126, Issue 3, 30 March 2005, Pages 173-181
Regulatory Peptides

Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons:: studies on chemically unfixed as well as fixed specimens

https://doi.org/10.1016/j.regpep.2004.09.008Get rights and content

Abstract

It is not known as to whether the Achilles and patellar tendons contain neurokinin-1 (NK-1) receptors. This is a drawback when considering the fact that pain symptoms are frequent in these and as recent studies show that the pain symptoms might be cured via interference with blood vessel function. In the present study, the human Achilles and patellar tendons were examined concerning immunohistochemical expression of the NK-1 receptor. Chemically unfixed and fixed specimens, TRITC and PAP stainings and a battery of NK-1 receptor antibodies, including antibodies against the C-terminus and the N-terminal region, were utilized. NK-1 receptor immunoreaction could be detected in inner parts of the walls of large blood vessels and in the walls of small blood vessels. To some extent, NK-1 immunoreaction was also detectable in small nerve fascicles and in tenocytes. It was found to be of utmost importance to apply both chemically unfixed and fixed specimens. The use of chemically unfixed tissue was found advantageous in order to depict the immunoreactions in the blood vessel walls. The observations represent new findings and are of relevance as substance P (SP) is known to be of importance where neurogenic angiogenesis contributes to diseases and as SP on the whole has profound effects concerning blood vessel regulation.

Introduction

Substance P (SP), isolated from horse brain and gut as early as 1931 [1] and consisting of 11 amino acids, is one member of the tachykinin family of peptides. The other members in this family are neurokinin A and neurokinin B. Three different tachykinin receptors have been identified; neurokinin-1 receptor (NK-1R), neurokinin-2 receptor (NK-2R) and neurokinin-3 receptor (NK-3R). Substance P has a high affinity for the NK-1R and binds to NK-2R with low affinity [2], [3]. The NK-1R has been cloned by Yokota et al. [4] and Hershey and Krause [2], has 407 amino acids and belongs to the family of G-protein-coupled receptors [5]. The N-terminal end and extracellular loops are responsible for the binding of SP [6], [7] and the intracellular C-terminus mediates the phosphorylation and internalization of the receptor after agonist binding and activation [8], [9].

A large number of immunohistochemical studies on NK-1R distribution in various tissues have been performed. However, varying descriptions have often been presented, presumably related to methodological aspects [10], [11] and the occurrence of different subtypes of the NK-1R [12], [13]. Another puzzling fact is that there often is a mismatch between occurrence of labelling with antibodies directed against the C-terminus of the NK-1R and SP-innervation [14], which may not only be related to the fact that neuropeptides like SP can diffuse for distances in the extracellular fluid [15]. Thus, interestingly, antibodies against the N-terminal end of the NK-1R have been found to label structures that are not labeled by antibodies against the C-terminus but which nevertheless respond to SP [16]. A truncated form of the NK-1R, lacking the intracellular C-terminus, exists [cf. Refs. [6], [16]], and that might be responsible for effects not mediated via the C-terminus of the full-length receptor. Thus, it has been found that neurons lacking immunoreactivity to the C-terminus respond to SP via receptors that pharmacologically show similarities to NK-1 receptors [17].

There is a presence of sensory neuropeptides, including SP, in the Achilles tendon of the rat [18], [19], [20], and it has been suggested that SP can be involved in the healing processes of ruptured rat Achilles tendons [21]. We have in a previous study noted the presence of SP-containing nerve fibers in the proximal insertion of another tendon, the tendon of extensor carpi radialis brevis (ECRB) muscle [22]. Recently, by using an antibody against the C-terminus of NK-1R, we found that specific immunoreactions were detected at the proximal insertion of the ECRB muscle [23]. The reactions were, however, restricted to nerve fascicles and to some freely coursing nerve fibers. Immunoreactions were not detected in blood vessel walls, a finding that is somewhat puzzling as it is well-known that SP in other parts of the body has vasoregulatory properties [24], [25].

There is no information on the possible occurrence of NK-1R in patellar or Achilles tendons, neither in man nor in animals. Thus, morphologic correlates for SP effects in these tissues are completely lacking. This is a drawback for the understanding of SP effects in the normal situation and for the understanding of the recent observations, made by the use of ultrasound and color Doppler, that dilated blood vessels occur in the regions of the structural changes in painful tendon disorders (“tendinosis”) [26]. The blood vessels were interpreted to represent neovascularization [26]. Therefore, the aim of the present study was to examine the pattern of distribution of NK-1R in the normal and tendinosis Achilles and patellar tendons of man. Chemically fixed and unfixed tissue samples, PAP and TRITC stainings and five different NK-1R antibodies, one of which was directed against the N-terminal end of the NK-1R, were utilized.

Section snippets

Individuals

In this investigation, samples from altogether 36 tendons were examined. Some of the individuals had normal tendons, while others were patients with a long duration of pain symptoms, and who by ultrasonography or MRI displayed structural tendon changes corresponding to the painful part of the tendon, and were classified to suffer from “tendinosis”. Achilles tendinosis was localized to the mid-portion of the tendon, while patellar tendinosis was localized to the proximal part of the tendon. In

Results

Specific immunoreactions were mainly detected in two of the structural components in the specimens; blood vessel walls and nerve fascicles/nerve fibers. To some extent, immunoreactions were also observed for tenocytes. Extensive initial stainings and continuous control stainings were performed in order to clarify the importance of different procedures in showing the specific immunoreactions in these structures. The protocols that gave a clear outcome for the different antibodies are shown in

Discussion

The present study shows that NK-1R immunoreaction was detectable in human patellar and Achilles tendons. The reactions that were clearly the most frequent were reactions seen in blood vessel walls. Sometimes, immunoreaction was also detected in nerve fibers occurring singly or being parts of nerve fascicles and in tenocytes. The levels of NK-1R immunoreaction in the blood vessels were found to show interindividual variations in the tendinosis groups, the reactions being most pronounced in

Acknowledgements

The authors wish to thank Ulla Hedlund and Lena Jonsson for excellent technical services. Financial support has been obtained from the Faculty of Medicine and Odontology, Umeå University, and the Swedish Research Council for Sports.

References (56)

  • S.V. Shrikhande et al.

    NK-1 receptor gene expression is related to pain in chronic pancreatitis

    Pain

    (2001)
  • G. Casini et al.

    Expression of the neurokinin 1 receptor in the rabbit retina

    Neuroscience

    (2002)
  • S. Forsgren et al.

    Pronounced substance P innervation in irradiation-induced enteropathy—a study on human colon

    Regul. Pept.

    (2000)
  • D. Renzi et al.

    Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine

    Am. J. Pathol.

    (2000)
  • J.L. Cook et al.

    Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons

    J. Orthop. Res.

    (2004)
  • E.F. Grady et al.

    Endocytosis and recycling of neurokinin 1 receptors in enteric neurons

    Neuroscience

    (1996)
  • Y. Torrens et al.

    Further evidence for the presence of ‘septide-sensitive’ tachykinin binding sites in tissues possessing solely NK1 tachykinin receptors

    Biochem. Biophys. Res. Commun.

    (2000)
  • F.F. Lam et al.

    Unique gradual and sustained vasodilator response to substance P in the rabbit knee joint

    Eur. J. Pharmacol.

    (2000)
  • S.D. Brain

    Sensory neuropeptides: their role in inflammation and wound healing

    Immunopharmacology

    (1997)
  • P.K. Towler et al.

    Activity of tachykinin NK1 and bradykinin B2 receptor antagonists, and an opioid ligand at different stimulation parameters in neurogenic inflammation in the rat

    Neurosci. Lett.

    (1998)
  • W.S. Kingery et al.

    A substance P receptor (NK-1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional syndrome type II

    Pain

    (2003)
  • R.J. Traub

    The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat

    Pain

    (1996)
  • M.J. Cumberbatch et al.

    Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK-1 receptor antagonist GR205171 in rats

    Neuropharmacology

    (1998)
  • U. von Euler et al.

    An unidentified depressor substance in certain tissue extracts

    J. Physiol. (Lond.)

    (1931)
  • A.D. Hershey et al.

    Molecular characterization of a functional cDNA encoding for the rat substance P receptor

    Science

    (1990)
  • S. Guard et al.

    Evidence for two types of tachykinin receptors on cholinergic neurons of the guinea pig ileum myenteric plexus

    Ann. N. Y. Acad. Sci.

    (1991)
  • M. Ohkubo et al.

    Molecular characterization of the three tachykinin receptors

  • U. Gether

    Uncovering molecular mechanisms involved in activation of G protein-coupled receptors

    Endocr. Rev.

    (2000)
  • Cited by (72)

    • Histologic grading correlates with inflammatory biomarkers in tibialis posterior tendon dysfunction

      2022, Foot and Ankle Surgery
      Citation Excerpt :

      While tendinopathy was once considered to be a non-inflammatory process, newer evidence suggest that pain-related inflammatory cytokines, matrix metalloproteases (MMPs), pain neurotransmitters and angiogenesis are highly associated with tendinopathy [5,8–10]. Also of interest are numerous studies that have demonstrated increased expression of pain neurotransmitters or receptors, such as glutamate, N-methyl-D-aspartate receptor type 1 (NMDAr1), substance P (SP), and calcitonin-gene-related-peptide (CGRP) in Achilles, patellar, extensor carpi radialis brevis, and carpal tunnel tendons [11–23]. There is still much unknown about tendinopathy, especially the TPT in TPTD.

    • The pathogenesis of Achilles tendinopathy: A systematic review

      2014, Foot and Ankle Surgery
      Citation Excerpt :

      It is recently hypotesised that the main cause of pain in patients with symptomatic mid-portion Achilles tendinopathy does not arise from the tendon proper but is generated by its surrounding tissues. This concept was elaborated in 7 articles [121–127]. Nine studies reported the hypothesis of the adhesions between plantaris longus tendon and Achilles tendons [128–136].

    View all citing articles on Scopus
    View full text